Abstract
The prevalence of drug resistant tuberculosis (TB) in Ethiopia in general, and Jimma area in particular, is not well documented. We conducted a study at Jimma University specialized hospital in southwest Ethiopia among new cases of smear positive TB patients to determine the pattern of resistance to first-line drugs. A health institution based cross sectional study was conducted from November 2010 to September 2011. Any newly diagnosed smear positive TB patient 18 years and above was included in the study. Demographic and related data were collected by trained personnel using a pretested structured questionnaire. Mycobacterial drug susceptibility testing (DST) to the first line drugs isoniazid (INH), rifampicin (RIF), ethambutol (EMB) and streptomycin (STM) was performed on cultures using the indirect proportion method. M. tuberculosis complex (MTBC) was identified with the Capilia TB-Neo test. 136 patients were enrolled in the study. Resistance to at least one drug was identified in 18.4%. The highest prevalence of resistance to any drug was identified against INH (13.2%) followed by STM (8.1%). There was no statistically significant difference in the proportion of any resistance by sex, age, HIV status and history of being im...Continue Reading
References
Dec 19, 2001·Emerging Infectious Diseases·P BifaniB N Kreiswirth
Nov 1, 2006·Emerging Infectious Diseases·Eva NathansonMario C Raviglione
Sep 20, 2007·Diagnostic Microbiology and Infectious Disease·Jann-Yuan WangPan-Chyr Yang
Nov 8, 2007·PloS One·Helen S CoxClair Mills
May 16, 2008·FEMS Immunology and Medical Microbiology·Amita Jain, Rajesh Mondal
Feb 28, 2009·The Lancet Infectious Diseases·Evan W OrensteinAlison P Galvani
Dec 4, 2009·PloS One·Francine MatthysMichael Kimerling
Jan 21, 2011·PloS One·Deus LukoyeMoses L Joloba
Apr 19, 2011·BMC Infectious Diseases·Jean-Paul Assam-AssamVincent P Titanji
Jan 21, 2012·BMC Research Notes·Christopher MuchwaMoses L Joloba
Dec 13, 2012·The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·M DaraUNKNOWN International Union Against Tuberculosis and Lung Disease
Citations
Sep 7, 2013·BMC Research Notes·Bereket WorkalemahuAbraham Aseffa
Dec 7, 2013·Ethiopian Journal of Health Sciences·Asres BerhanDesalegn Yizengaw
Jun 1, 2016·International Journal of Mycobacteriology·Mulualem TadesseGemeda Abebe
Sep 4, 2015·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Girma MulisaGodana Jarso
May 17, 2014·Tuberculosis Research and Treatment·Berhanu SeyoumAbraham Aseffa
Jul 3, 2015·BMC Public Health·Kedir AbdellaGemeda Abebe
Jun 21, 2015·BMC Public Health·Kelemework AdaneAbraham Aseffa
Oct 21, 2016·BMC Infectious Diseases·Glennah KeruboSamuel Kariuki
Dec 29, 2016·PloS One·Renata Báez-SaldañaAlfredo Ponce-de-León
Oct 16, 2018·MicrobiologyOpen·Gemeda AbebeGobena Ameni
Sep 26, 2017·PloS One·Baba Maiyaki MusaMuktar H Aliyu
Feb 17, 2015·Antimicrobial Resistance and Infection Control·Fantahun BiadglegneArne C Rodloff
Apr 27, 2019·BMC Infectious Diseases·Amir AlelignBeyene Petros
Jul 20, 2016·BMC Public Health·Shallo Daba HamusseBernt Lindtjørn
Nov 17, 2016·International Journal of Mycobacteriology·Kebede TesfayKelemework Adane
Jan 7, 2017·BMC Research Notes·Wondemagegn MuluDereje Abate
Jun 1, 2018·Journal of Pathogens·Solomon Weldegebreal AsgedomHailay Gebreyesus
Jun 27, 2018·Tropical Diseases, Travel Medicine and Vaccines·Tadele GirumMisgun Shewangizaw
Aug 31, 2019·Advances in Preventive Medicine·Alemayehu RetaAbeba Mengist
Feb 16, 2018·PloS One·Melaku TilahunAbraham Aseffa
Oct 11, 2020·BMJ Global Health·Anita SvadzianClaudia M Denkinger
Nov 5, 2020·PloS One·Araya Gebreyesus WasihunGenet Gebrehiwet Hailu
May 6, 2021·Infectious Diseases and Therapy·Araya Gebreyesus WasihunTsehaye Asmelash Dejene